Treatment Registry
TR-0636 ActiveRecorded September 2, 2026Last verified September 3, 2026

Brand tirzepatide

Sold by Immortals · Injection, pen · every brand tirzepatide record

What you actually pay

Per month

$600

Medication · Zepbound KwikPen$600

Added from the figures recorded below.

Price

TermPer monthCharged today
Zepbound KwikPen

Zepbound® KwikPen® (tirzepatide) From $600/mo* Activates both GLP-1 and GIP receptors, the two gut hormones that signal appetite and satiety, supporting long-term weight loss.

source, read September 2, 2026

Per month$600Charged today$600
Visit Immortals

We earn nothing from this link. Immortals has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

Cancellation“Cancellation. You can cancel your subscription at any time through the settings in your account. When you cancel a paid subscription, you cancel only future charges associated with your subscription, but the cancellation will become effective at the end of your current subscription period.”
MembershipNone. “Immortals Medicine has no membership fees or insurance requirements.”

Not yet checked: pharmacy, states, prescriber and consult fee.

Recorded from immortals.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0636
Readings
2

Related records

What else Immortals sells

All Immortals programs and terms

Brand tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 59 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Immortals brand tirzepatide (TR-0636). Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0636

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.